Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The Gut Resistome during Hematopoietic Stem Cell Transplantation in Children

Sarah M. Heston, Rebecca R. Young, Kirsten Jenkins, Paul L. Martin, Andre Stokhuyzen, Doyle V. Ward, Shakti K. Bhattarai, View ORCID ProfileVanni Bucci, Mehreen Arshad, Nelson J. Chao, Patrick C. Seed, View ORCID ProfileMatthew S. Kelly
doi: https://doi.org/10.1101/2022.07.07.22277185
Sarah M. Heston
1Division of Pediatric Infectious Diseases, Duke University Medical Center, Durham, NC
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sarah.heston{at}duke.edu
Rebecca R. Young
1Division of Pediatric Infectious Diseases, Duke University Medical Center, Durham, NC
2Duke Clinical Research Institute, Durham, NC
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kirsten Jenkins
1Division of Pediatric Infectious Diseases, Duke University Medical Center, Durham, NC
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul L. Martin
3Division of Pediatric Transplant and Cellular Therapy, Duke University Medical Center, Durham, NC
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andre Stokhuyzen
3Division of Pediatric Transplant and Cellular Therapy, Duke University Medical Center, Durham, NC
MSN, RN, CPNP-AC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Doyle V. Ward
4Center for Microbiome Research, University of Massachusetts Medical School, Worcester, MA
5Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shakti K. Bhattarai
5Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vanni Bucci
5Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vanni Bucci
Mehreen Arshad
6Division of Pediatric Infectious Diseases, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nelson J. Chao
7Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC
MD MBA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick C. Seed
6Division of Pediatric Infectious Diseases, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew S. Kelly
1Division of Pediatric Infectious Diseases, Duke University Medical Center, Durham, NC
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew S. Kelly
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Children undergoing hematopoietic stem cell transplantation (HCT) are at high risk of acquiring antibiotic-resistant bacteria. Few prior studies examined antibiotic resistance genes (ARGs) within the gut metagenomes of children undergoing HCT.

Methods We conducted a longitudinal study of children (age <18 years) undergoing HCT at a single institution. We performed shotgun metagenomic sequencing of fecal samples collected between days -30 and +100 relative to HCT. We evaluated the effects of aerobic (cefepime, vancomycin, fluoroquinolones, aminoglycosides, macrolides, and trimethoprim-sulfamethoxazole) and anaerobic (piperacillin-tazobactam, carbapenems, metronidazole, and clindamycin) antibiotic exposures on the diversity and composition of the gut microbiome and resistome.

Findings Using metagenomic data from 693 fecal samples collected from 80 children, we identified 350 unique ARGs. The most frequent ARGs identified encode resistance to tetracycline (n=91), beta-lactams (n=80), and fluoroquinolones (n=76). Both aerobic and anaerobic antibiotic exposures were associated with a decrease in the number of bacterial species (aerobic, β=0.72, 95% CI: 0.66, 0.79; anaerobic, β=0.68, 95% CI: 0.61, 0.76) and the number of unique ARGs (aerobic, β=0.83, 95% CI: 0.76, 0.91; anaerobic, β=0.84, 95% CI: 0.76, 0.93) within the gut metagenome. However, only anaerobic antibiotics were associated with an increase in the number of newly acquired ARGs (29%, 95% CI: 10%, 52%) and the abundance of ARGs (95%, 95% CI: 59%, 138%) in the gut resistome. Specific antibiotic exposures were associated with distinct changes in the number and abundance of resistance genes for individual antibiotic classes.

Interpretation The gut metagenome and resistome of children are highly dynamic throughout HCT, driven largely by antibiotic exposures. Compared to antibiotics without anaerobic activity, anaerobic antibiotics were associated with increased microbiome instability and expansion of the gut resistome.

Funding Antibacterial Resistance Leadership Group, National Institutes of Health, Duke Children’s Health & Discovery Initiative, Children’s Miracle Network Hospitals

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Research reported in this publication was supported in part by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number UM1AI104681. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was additionally supported by the National Institute of Child Health and Human Development of the National Institutes of Health [T32HD094671 to S.M.H.], the National Human Genome Research Institute of the National Institutes of Health [T32 HG008955 to S.M.H.], the Translating Duke Health Ending Disease Where it Begins Working Group [to S.M.H.], the local efforts of the Duke Childrens Office of Development and its Childrens Miracle Network Hospitals fundraising corporate partnerships and programs [to S.M.H.], and a National Institutes of Health Career Development Award [K23-AI135090 to M.S.K.].

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

We obtained informed consent from participants legal guardians prior to enrollment, and the study protocol was approved by the Duke University Health System Institutional Review Board.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data not included in the manuscript will be available by request to the corresponding authors. All metagenomic data will be uploaded to the Sequence Read Archive.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted July 07, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The Gut Resistome during Hematopoietic Stem Cell Transplantation in Children
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The Gut Resistome during Hematopoietic Stem Cell Transplantation in Children
Sarah M. Heston, Rebecca R. Young, Kirsten Jenkins, Paul L. Martin, Andre Stokhuyzen, Doyle V. Ward, Shakti K. Bhattarai, Vanni Bucci, Mehreen Arshad, Nelson J. Chao, Patrick C. Seed, Matthew S. Kelly
medRxiv 2022.07.07.22277185; doi: https://doi.org/10.1101/2022.07.07.22277185
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The Gut Resistome during Hematopoietic Stem Cell Transplantation in Children
Sarah M. Heston, Rebecca R. Young, Kirsten Jenkins, Paul L. Martin, Andre Stokhuyzen, Doyle V. Ward, Shakti K. Bhattarai, Vanni Bucci, Mehreen Arshad, Nelson J. Chao, Patrick C. Seed, Matthew S. Kelly
medRxiv 2022.07.07.22277185; doi: https://doi.org/10.1101/2022.07.07.22277185

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pediatrics
Subject Areas
All Articles
  • Addiction Medicine (434)
  • Allergy and Immunology (758)
  • Anesthesia (222)
  • Cardiovascular Medicine (3314)
  • Dentistry and Oral Medicine (366)
  • Dermatology (282)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1175)
  • Epidemiology (13397)
  • Forensic Medicine (19)
  • Gastroenterology (900)
  • Genetic and Genomic Medicine (5175)
  • Geriatric Medicine (482)
  • Health Economics (785)
  • Health Informatics (3284)
  • Health Policy (1145)
  • Health Systems and Quality Improvement (1198)
  • Hematology (432)
  • HIV/AIDS (1023)
  • Infectious Diseases (except HIV/AIDS) (14651)
  • Intensive Care and Critical Care Medicine (915)
  • Medical Education (478)
  • Medical Ethics (128)
  • Nephrology (525)
  • Neurology (4950)
  • Nursing (262)
  • Nutrition (734)
  • Obstetrics and Gynecology (888)
  • Occupational and Environmental Health (797)
  • Oncology (2530)
  • Ophthalmology (730)
  • Orthopedics (284)
  • Otolaryngology (348)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (547)
  • Pediatrics (1305)
  • Pharmacology and Therapeutics (552)
  • Primary Care Research (558)
  • Psychiatry and Clinical Psychology (4223)
  • Public and Global Health (7525)
  • Radiology and Imaging (1714)
  • Rehabilitation Medicine and Physical Therapy (1019)
  • Respiratory Medicine (981)
  • Rheumatology (480)
  • Sexual and Reproductive Health (500)
  • Sports Medicine (425)
  • Surgery (551)
  • Toxicology (72)
  • Transplantation (237)
  • Urology (206)